文献速递鼻科小儿耳鼻咽喉

球囊鼻窦扩张术治疗儿童慢性鼻窦炎的前瞻性多中心评估

Prospective, multicenter evaluation of balloon sinus dilation for treatment of pediatric chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2016-11-26

这项前瞻性、多中心、单臂研究纳入50例药物治疗失败的2至21岁慢性鼻窦炎患儿,行球囊鼻窦扩张术并随访至术后6个月。共尝试157处鼻窦扩张(上颌窦98处、额窦30处、蝶窦29处),全部成功且无并发症。SN-5评分从基线4.6±1.2降至6个月1.7±0.8(p<0.0001),92%患儿达到≥1.0的MCID改善。

要点

  • 50例2至21岁慢性鼻窦炎患儿接受球囊鼻窦扩张术,157处鼻窦扩张全部成功且无并发症。
  • 全部患儿SN-5评分从基线4.6±1.2改善至6个月1.7±0.8(p<0.0001),92%达到MCID≥1.0。
  • 2至12岁单独行球囊扩张者SN-5亦显著改善(4.5±1.0 vs 1.9±0.8;p<0.0001)。

核心结论

  • 球囊鼻窦扩张术对2岁及以上慢性鼻窦炎患儿是安全的,并似乎有效。

研究设计与样本

  • 前瞻性、多中心、单臂研究,纳入药物治疗失败的2至21岁慢性鼻窦炎患儿50例,在4个中心治疗并随访至术后6个月。

主要发现

  • 50例中33例为2至12岁(平均年龄6.6±2.2岁),17例为>12至21岁(平均年龄15.7±2.5岁)。
  • 共尝试157处鼻窦扩张(上颌窦98处、额窦30处、蝶窦29处),全部成功且无并发症。
  • 全部患儿SN-5评分从基线4.6±1.2改善至6个月1.7±0.8(p<0.0001),92%患儿改善达到MCID≥1.0。
  • 2至12岁单独行球囊扩张的患儿SN-5评分从基线4.5±1.0改善至随访1.9±0.8(p<0.0001)。
  • 青少年SNOT-22平均评分从基线42.2±19.2改善至6个月10.4±9.7(p<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although balloon sinus dilation is a treatment option for adults with chronic rhinosinusitis (CRS), there have been few studies performed in pediatric patients. METHODS: This study was designed as a prospective, multicenter, single-arm investigation. Children (2 to 21 years old) with CRS who had failed medical management were treated with balloon sinus dilation and followed to 6 months postprocedure. RESULTS: Fifty children were treated at 4 centers; 33 participants were 2 to 12 years old (mean ± standard deviation age: 6.6 ± 2.2 years) and 17 participants were >12 to 21 years (mean age: 15.7 ± 2.5 years). A total of 157 sinus dilations were attempted (98 maxillary, 30 frontal, and 29 sphenoid sinuses) and all were successful with no complications. Significant improvement in the Sinus and Nasal Quality of Life Survey (SN-5) was seen for all children between baseline and 6 months (4.6 ± 1.2 vs 1.7 ± 0.8; p < 0.0001) and 92% improved by a minimal clinically important difference (MCID) of 1.0 or more. Those children aged 2 to 12 years with standalone balloon dilation also showed significant SN-5 improvements between baseline and follow-up (4.5 ± 1.0 vs 1.9 ± 0.8; p < 0.0001). Multivariate regression analysis showed no differences or associations of SN-5 improvement at 6 months with the presence of allergy, asthma, or concomitant procedures. For adolescents, overall 22-item Sino-Nasal Outcome Test (SNOT-22) mean scores were also significantly improved at 6 months (42.2 ± 19.2 vs 10.4 ± 9.7; p < 0.0001). CONCLUSION: Balloon sinus dilation is safe and appears effective for children with CRS aged 2 years and older.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Soler ZM, Rosenbloom JS, Skarada D, et al. Prospective, multicenter evaluation of balloon sinus dilation for treatment of pediatric chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016. PMID: 27888649. doi:10.1002/alr.21889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。